Is PSMA PET/CT More Beneficial than Bone Scintigraphy in Detecting Bone Lesions in Cases of High-Risk Prostate Cancer?

A new comparative study found the use of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) led to treatment changes in nearly 20 percent of patients with high-risk prostate cancer.

Read the full article here

Related Articles